Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LSD1/HDAC6-IN-1 is an orally active compound that functions as a dual inhibitor, targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6). This compound demonstrates promising anti-tumor activity and is particularly valuable for research focused on multiple myeloma (MM) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 359.00 | |
10 mg | Inquiry | $ 578.00 | |
25 mg | Inquiry | $ 1,160.00 |
Description | LSD1/HDAC6-IN-1 is an orally active compound that functions as a dual inhibitor, targeting lysine specific demethylase 1 (LSD1) and histone deacetylase 6 (HDAC6). This compound demonstrates promising anti-tumor activity and is particularly valuable for research focused on multiple myeloma (MM) [1]. |
In vitro | LSD1/HDAC6-IN-1 shows superior potency in multiple MM lines[1]. |
In vivo | LSD1/HDAC6-IN-1 is efficacy in the MM.1S xenograft model[1]. |
Synonyms | LSD1/HDAC6-IN-1 |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LSD1/HDAC6-IN-1 LSD-1/HDAC6-IN-1 LSD1/HDAC6 IN 1 LSD1/HDAC6IN1 inhibitor inhibit